
Humanised antihuman IL-6R antibody with interferon inhibits renal cell carcinoma cell growth in vitro and in vivo through suppressed SOCS3 expression
Keywords: Renal cell carcinoma; Interferon; IL-6; Tocilizumab; IL-6 receptor; SOCS3